BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
James Neuberger. Encyclopedia of Gastroenterology2020; : 455 doi: 10.1016/B978-0-12-801238-3.65787-2
2
Patrizia Burra, Kryssia I Rodriguez-Castro. Neoplastic disease after liver transplantation: Focus on <italic>de novo</italic> neoplasmsWorld Journal of Gastroenterology 2015; 21(29): 8753-8768 doi: 10.3748/wjg.v21.i29.8753
3
Y Lazebnik, G E Parris. Comment on: ‘Guidelines for the use of cell lines in biomedical research’: human-to-human cancer transmission as a laboratory safety concernBritish Journal of Cancer 2015; 112(12): 1976 doi: 10.1038/bjc.2014.656
4
Sarah E. Rudasill, Amit Iyengar, Yas Sanaiha, Habib Khoury, Alexandra L. Mardock, Sohail Sareh, Peyman Benharash. Donor history of malignancy: A limited risk for heart transplant recipientsClinical Transplantation 2020; 34(2) doi: 10.1111/ctr.13762
5
Mark W. Russo. The Care of the Postliver Transplant PatientJournal of Clinical Gastroenterology 2017; 51(8): 683 doi: 10.1097/MCG.0000000000000886
6
Francesca Marcon, Andrea Schlegel, David C. Bartlett, Marit Kalisvaart, Dawn Bishop, Hynek Mergental, Keith J. Roberts, Darius F. Mirza, John Isaac, Paolo Muiesan, M. Thamara Perera. Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft UseTransplantation 2018; 102(5): e211 doi: 10.1097/TP.0000000000002127
7
Mohamad A. Mouchli, Siddharth Singh, Edward V. Loftus, Lisa Boardman, Jayant Talwalkar, Charles B. Rosen, Julie K. Heimbach, Russell H. Wiesner, Bashar Hasan, John J. Poterucha, Watt D. Kymberly. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing CholangitisTransplantation 2017; 101(8): 1859 doi: 10.1097/TP.0000000000001725
8
I. Yu. Kolyshev, S. E. Voskanyan, M. V. Shabalin, A. I. Artemyev, V. S. Rudakov, A. P. Maltseva, A. N. Bashkov, V. E. Syutkin, K. K. Gubarev, D. S. Svetlakova, M. V. Popov, A. I. Sushkov, Z. A. Sadykhov. Extrahepatic malignancies in a liver transplant recipient from a living related donorTransplantologiya. The Russian Journal of Transplantation 2020; 12(3): 199 doi: 10.23873/2074-0506-2020-12-3-199-212
9
Yasir Al-Azzawi, Lance L. Stein, Roshan Shrestha, Devina Bhasin, Steven J. Citron, Raymond A. Rubin. Donor-Derived Hepatic Neuroendocrine TumorTransplantation Direct 2016; 2(7): e88 doi: 10.1097/TXD.0000000000000549
10
James Neuberger. An update on liver transplantation: A critical reviewJournal of Autoimmunity 2016; 66: 51 doi: 10.1016/j.jaut.2015.08.021
11
Venkata S. Katabathina, Christine O. Menias, Varaha S. Tammisetti, Meghan G. Lubner, Ania Kielar, Akram Shaaban, Joseph Mansour, Venkateshwar R. Surabhi, Amy K. Hara. Malignancy after Solid Organ Transplantation: Comprehensive Imaging ReviewRadioGraphics 2016; 36(5): 1390 doi: 10.1148/rg.2016150175
12
Sarah Shalaby, Patrizia Burra. De novo and recurrent malignancyBest Practice & Research Clinical Gastroenterology 2020; : 101680 doi: 10.1016/j.bpg.2020.101680